Home/Products /vilanterol-25mcg-fluticasone-furotae-100mcg-rota-cap

Pulmonary Rota cap in pharma franchise in Meghalaya

Pulmonary Rota cap in PCD pharma franchise in Jaipur

Pulmonary Rota cap in top pharma company in Nagpur

Pulmonary Rota cap in pcd pharma supplier in Bhopal

Pulmonary Rota capin phama franchise company in India

Pulmonary Rota cap in phama distributor in Howrah

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Vilanterol 25mcg + Fluticasone Furoate 100mcg at Best Price in PCD Medical Pharma for Respiratory Health

Vilanterol 25mcg + Fluticasone Furoate 100mcg at Best Price from Leading 3rd Party Pharma Manufacturers in India for Asthma & COPD

Vilanterol 25mcg + Fluticasone Furoate 100mcg at Best Price from Top Pharmaceutical Exporters in India for Asthma & COPD Care

Vilanterol 25mcg + Fluticasone Furoate 100mcg at Best Price in Pharma Products Company for Respiratory Management

Flutialfa VF Best Price in Respiratory Pharma Franchise for Asthma & COPD Treatment

Flutialfa VF Rota cap

Composition : Vilanterol 25mcg + Fluticasone Furotae 100mcg rota cap

Dosage Form : Rota cap

Packaging Type : Bottle

Packaging : 30 Capsules

Price : ₹1/-

Please Contact For Best Price

Flutialfa VF is a combination inhalation therapy designed to provide effective management of asthma and chronic obstructive pulmonary disease (COPD). Each Rota Cap contains Vilanterol (25 mcg), a long-acting beta-agonist (LABA), and Fluticasone Furoate (100 mcg), a potent inhaled corticosteroid (ICS). This dual-action formulation works synergistically to improve lung function, reduce inflammation, and alleviate respiratory symptoms.

Vilanterol acts by stimulating beta-2 adrenergic receptors in the airway smooth muscle, leading to bronchodilation and improved airflow. This helps to relieve symptoms such as wheezing and shortness of breath. Fluticasone Furoate, on the other hand, reduces airway inflammation and hyperreactivity, addressing the underlying causes of asthma and COPD. Together, these components provide comprehensive control of respiratory conditions, allowing patients to breathe more easily and engage in daily activities with greater comfort.

About the Product

Common side effects may include throat irritation, hoarseness, headache, and increased risk of respiratory infections. Some patients may experience palpitations or muscle cramps. It is essential to monitor for any unusual symptoms during treatment.

Flutialfa VF is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults.

Flutialfa VF should be used only as prescribed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms do not improve or worsen

Store Flutialfa VF in a cool, dry place, away from direct sunlight and moisture. Ensure that it is kept out of reach of children.